Skip to content

Clinical Study on the Treatment of Mixed Component Cornea for High Risk Keratoplasty

Suppression of Graft Rejection Using Mixed Component Cornea in the High-risk Keratoplasty,A Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04490902
Enrollment
80
Registered
2020-07-29
Start date
2020-08-18
Completion date
2023-07-31
Last updated
2022-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Transplantation

Keywords

High-risk corneal transplantation, Penetrating keratoplasty, Limbal transplantation

Brief summary

Because of the immunologically privileged nature of the cornea, the graft rejection rate is less than 10% for low-risk keratoplasty. But when the cornea performed 2 or more quadrants of corneal neovascularization after ocular trauma or infection, the graft rejection rate is more than 65%, it is called high-risk keratoplasty. This study will observe the graft survival of high-risk corneal transplantation using mixed component cornea from different donors.

Detailed description

Ocular trauma or infection lead to corneal limbal stem cell deficiency and central corneal opacification which could only be treated by central penetrating keratoplasty and limbal transplantation, but the rejection rate is very high. In clinical, we found that limbal transplantation combined with central penetrating keratoplasty from different donors can keep the graft transparent for a long time, this result also be found in organ transplantation, multiple donor organ transplantation could reduce rejection risk in liver and kidney transplantation. Therefore, it is speculated that there are different MHC antigens from different donors, which cause different reactions after transplantation. Because there are a large number of Langerhans cells, abundant blood vessels and lymphatic in the limbal, so the rejection occurs early and severely. Continuous and intense limbal rejection leads to the depletion of recipient T cells, lead to the immune tolerance of another donor's central corneal tissue. In this project, central penetrating keratoplasty and limbal transplantation from different donors will be carried out and the graft survival of high-risk corneal transplantation will be observed in clinical, to find a new method for high-risk corneal transplant patients.

Interventions

PROCEDURELimbal transplantation combined with central penetrating keratoplasty

Limbal transplantation combined with central penetrating keratoplasty with single donor cornea

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Central corneal opacity involving full layer * Corneal neovascularization in two or more quadrants * Patients must be willing and able to return for scheduled follow-up examinations for 12 months after surgery * Ages:18 -70 Years

Exclusion criteria

* Central corneal opacity not involving the endothelial layer * Less than two quadrants of corneal neovascularization * History of Stevens-Johnson syndrome or Sjogren's syndrome * Severe eyelid and conjunctival scar * Loss of vision in contralateral eye * Pregnant and lactating women

Design outcomes

Primary

MeasureTime frameDescription
The rate of corneal graft rejection at 12 months12 monthsThe rejection index of corneal transplantation will be observed by slit lamp after surgery

Secondary

MeasureTime frameDescription
The changes of corneal thickness depthbaseline (Before surgery), 1 week, 1 month, 3 months, 6 months, 12 monthsCorneal thickness depth will be measured by anterior segmental OCT and compared with preoperative
Reconstruction of corneal limbalbaseline (Before surgery), 1 week, 1 month, 3 months, 6 months, 12 monthsConfocal microscopy will be used to define whether the structure of corneal limbal has reconstructed
The changes of best corrected visual acuityBefore surgery, 1 week, 1 month, 3 months, 6 months, 12 monthsBest corrected visual acuity in different point will be compared with preoperative
The rate of presence of goblet cells containing conjunctival epithelium on the corneal surface by impression cytologybaseline (Before surgery), 1 week, 1 month, 3 months, 6 months, 12 monthsDetects whether conjunctival epithelial and goblet cells have invaded the corneal surface by impression cytology, to observe the reconstruction of limbal function
Endothelial Cell Densitybaseline (Before surgery), 1 week, 1 month, 3 months, 6 months, 12 monthsEndothelial Cell Density will be measured by specular microscope to evaluate the loss of endothelial cells

Other

MeasureTime frameDescription
Intraocular pressureBefore surgery, 1 week, 1 month, 3 months, 6 months, 12 monthsIntraocular pressure will be measured by non contact tonometer as safety index

Countries

China

Contacts

Primary ContactTing Huang, MD, PHD
qingerdong@126.com86-13552338050

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026